Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 926-950 of 2,022
CompletedNCT02739932

Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study

This study exists to understand what helps brain scans or other body measurements work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 12 Years to 25 Years
Countries
Canada
Sponsor
University of Calgary
Condition
Depression
CompletedNCT02845440

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
CompletedNCT03630822

Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity I or Schizoaffective Disorder

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Schizophrenia
CompletedNCT03156504

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression
CompletedNCT03959735

High Intensity Interval Training in Severe Mental Illness

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression
WithdrawnNCT03842345

DELPhI Evaluation of Psychiatric Conditions

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

DepressionOtherOver 18 Years
Countries
Global
Sponsor
QuantalX Neuroscience
Condition
Depression
CompletedNCT03386851

Abilify Maintena PMS in Schizophrenia Patients or Bipolarity type I

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherOver 19 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
CompletedNCT01866098

Naltrexone for Antipsychotic-Induced Weight Gain

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
CompletedNCT02037581

Integrated Care Including Assertive Community Treatment in Early Psychosis

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 29 Years
Countries
Germany
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Condition
Schizophrenia
CompletedNCT02188732

Self-Management Training and Automated Telehealth to Improve SMI Health Outcomes

This study exists to see whether smoking support or smoking-related treatment can play a useful role in care. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT04068467

Evaluation of mHealth for Serious Mental Illness

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. For people living with Schizophrenia, that matters because support often needs to fit around real routines and access barriers.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
CompletedNCT03822416

Treating Smokers With Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Depression
CompletedNCT00666432

Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 15 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
CompletedNCT01948024

Bio-equivalence Study Between SAPHRIS and Asenapine

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Sun Pharmaceutical Industries Limited
Condition
Schizophrenia
CompletedNCT03404882

Peer Support Experience for Patients Discharged From Acute Psychiatric Care

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
CompletedNCT03050853

The Appeal and Impact of E-cigarettes in Smokers With SMI

This study exists to see whether smoking support or smoking-related treatment can make care clearer and more responsive. Researchers are trying to understand whether smoking support or smoking-related treatment can work better when mental health difficulties overlap with substance use.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
Schizophrenia
CompletedNCT01053429

A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOther
Countries
Global
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
CompletedNCT00650611

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

SchizophreniaOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
CompletedNCT02756065

Connectomics in Psychiatric Classification of Bipolarity and Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Washington University Early Recognition Center
Condition
Schizophrenia
CompletedNCT00825539

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

This study exists to better understand the safety of the medication AQW051 and how manageable it feels in practice. Researchers are trying to understand whether the medication AQW051 can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Novartis Pharmaceuticals
Condition
Schizophrenia
CompletedNCT03062267

Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia